The safety and efficacy of conversion of brand-name simvastatin(zocor) to generic simvastain (zolotin) in a teaching hospital in taiwan

• In: Hospital Pharmacy Section - Posters
• At: Beijing (China) (2007)
• Type: Poster
• Poster code: HPS-P-116
• By: TSAI, PINE-CHUN (E-Da Hospital, I-Shou University, Kaohsiung, China Taiwan)
• Co-author(s): Hsiu-Ling, Chang (E-Da Hospital, I-Shou University, KAOHSIUNG, China Taiwan)
  Mei-Fang, Lin (E-Da Hospital, I-Shou University, KAOHSIUNG, China Taiwan)
  Thung-Lip, Lee (E-Da Hospital, I-Shou University, KAOHSIUNG, China Taiwan)
  Chau-Chung, Wu (E-Da Hospital, I-Shou University, KAOHSIUNG, China Taiwan)
  
• Abstract:

  Background: Dyslipidemia is well documented to increase the risk of coronary artery
  
  disease (CAD). The 3-hydroxy -3-methylglutary1 coenzyme A(HMG-CoA) reductase
  
  inhibitors (statins) are well established to reduce the risk of cardiovascular disease in
  
  this field. Due to the increasingly high costs of medication in Taiwan, the government
  
  has set ..

The access to the whole abstract and if available the presentation file is available to FIP members and to congress participants of that specific congress. Please login